Precursor effect on the hydrothermal synthesis of pure ZnO nanostructures and enhanced photocatalytic performance for norfloxacin degradation
Chemical Engineering Journal · 2024-09 · 496 · 154374
DOI: 10.1016/j.cej.2024.154374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-09. Verfasst von Ramon Resende Leite und 6 weiteren Autor:innen. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: State of Sao Paulo Research Foundation, National Council for Scientific and Technological Development, Coordination of Higher Education Personnel Improvement.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- State of Sao Paulo Research Foundation
- National Council for Scientific and Technological Development
- Coordination of Higher Education Personnel Improvement
Zitieren
APA
Leite, R. R., Colombo, R., Júnior, F. E. B., Lanza, M. R. D. V., Barud, H. D. S., Afonso, C. R. M., & Bernardi, M. I. B. (2024). Precursor effect on the hydrothermal synthesis of pure ZnO nanostructures and enhanced photocatalytic performance for norfloxacin degradation. Chemical Engineering Journal, 496, 154374. https://doi.org/10.1016/j.cej.2024.154374
Vancouver
Leite RR, Colombo R, Júnior FEB, Lanza MRDV, Barud HDS, Afonso CRM, et al. Precursor effect on the hydrothermal synthesis of pure ZnO nanostructures and enhanced photocatalytic performance for norfloxacin degradation. Chemical Engineering Journal. 2024;496:154374. doi:10.1016/j.cej.2024.154374
BibTeX
@article{Leite2024,
author = {Leite, Ramon Resende and Colombo, Renata and Júnior, Fausto Eduardo Bimbi and Lanza, Marcos Roberto de Vasconcelos and Barud, Hernane da Silva and Afonso, Conrado Ramos Moreira and Bernardi, Maria Inês Basso},
title = {Precursor effect on the hydrothermal synthesis of pure ZnO nanostructures and enhanced photocatalytic performance for norfloxacin degradation},
journal = {Chemical Engineering Journal},
year = {2024},
volume = {496},
pages = {154374},
doi = {10.1016/j.cej.2024.154374}
}
EUVIMED